Picture of Vitaspring Biomedical Co. logo

VSBC Vitaspring Biomedical Co. Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Annual balance sheet for Vitaspring Biomedical Co., fiscal year end - January 31st, USD millions except per share, conversion factor applied.

2019
January 31st
2020
January 31st
2021
January 31st
C2022
January 31st
2023
January 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments000.0450.1070.03
Net Total Accounts Receivable
Net Total Receivables2.950.38
Total Inventory
Prepaid Expenses
Total Current Assets0.0100.1893.060.437
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.00100.5250.305
Other Long Term Assets
Total Assets0.01100.1893.60.766
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities0.01800.0931.743.07
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities0.01800.0932.033.16
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity-0.00700.0961.58-2.4
Total Liabilities & Shareholders' Equity0.01100.1893.60.766
Total Common Shares Outstanding